6.2 Serum, Plasma, Whole Blood, and Anticoagulation
Key Takeaways
- Serum is the liquid remaining after blood clots (fibrinogen is consumed in the fibrin clot); plasma is the liquid portion of anticoagulated blood and still contains fibrinogen.
- Whole-blood assays such as a complete blood count (CBC) require mixed, unclotted blood with cells left in suspension; they cannot be performed on serum.
- EDTA chelates calcium (hematology); sodium citrate binds calcium at a 9:1 blood-to-anticoagulant ratio (coagulation); heparin inhibits thrombin (plasma chemistry); fluoride/oxalate inhibits glycolysis for glucose.
- Invert anticoagulant tubes the manufacturer-specified number of times immediately after fill; shaking hemolyzes cells, and skipped mixing leaves residual clots.
- Gel-separator tubes (SST or PST) form a barrier after centrifugation so cells do not continue to metabolize analytes in the liquid.
AMT lists three related competencies together: know the differences among serum, plasma, and whole blood (II.3.A.2); understand clotted versus anticoagulated blood (II.3.A.3); and use the proper anticoagulant for each analysis, including the effects of the wrong one (II.3.B.3). Order of draw, short draws, and hemolysis are Chapter 7. This section is the foundation those later items sit on: if you cannot say whether a test needs cells, clotting factors, or a cell-free liquid, you will pick the wrong tube even if you recite colors in the correct sequence.
Quick Answer: Whole blood = cells plus liquid, kept from clotting. Plasma = liquid from anticoagulated blood (fibrinogen still there). Serum = liquid after a clot forms (fibrinogen used up). Mix anticoagulant tubes by gentle inversion. EDTA is hematology, citrate is coagulation, heparin is plasma chemistry, fluoride/oxalate preserves glucose.
Whole blood, plasma, and serum
Whole blood is the specimen as it circulates: erythrocytes, leukocytes, and platelets suspended in liquid. For laboratory use, whole blood must be mixed with an anticoagulant so it does not clot, and it must be mixed again before testing so cells do not settle. A complete blood count (CBC), blood-film review, many point-of-care glucose meters, and most waived whole-blood immunoassays are whole-blood tests. If the tube clots, the specimen is no longer whole blood for those assays.
Plasma is the liquid portion of blood that still contains fibrinogen and the other coagulation proteins. You obtain plasma by drawing into an anticoagulant, mixing, then centrifuging to sediment the cells. The supernatant is plasma.
Serum is the liquid remaining after blood has been allowed to clot. During clotting, fibrinogen is converted to fibrin and is trapped in the clot with the cells. After centrifugation, the supernatant is serum: it lacks fibrinogen. Many chemistry, serology, and blood-bank antibody methods are validated on serum. They are not automatically validated on plasma, and plasma methods are not automatically validated on serum. Using the wrong liquid is an off-label specimen type (Chapter 5) as well as a preanalytical error.
| Feature | Whole blood | Plasma | Serum |
|---|---|---|---|
| Cells present | Yes, in suspension | No (spun down) | No (trapped in the clot, then spun) |
| Fibrinogen | Present (until a clot forms) | Present | Consumed in the clot |
| How you get it | Anticoagulant, mixed, not used as a cell-free liquid | Anticoagulant, mixed, centrifuged | No anticoagulant or clot activator, clot, centrifuge |
| Typical assays | CBC, some POC glucose and A1C, many waived whole-blood kits | Coagulation (citrate plasma); many chemistry panels (heparin plasma) | Many chemistry and serology methods |
| Fatal mix-up | Clotted EDTA is not a CBC | Calling serum plasma because both look yellow | Sending plasma for a serum-only method |
Visual color does not identify the specimen. Fresh plasma and serum can both be straw-yellow. The tube additive and whether a clot formed are what distinguish them.
How a clot forms
Hemostasis in the tube follows the same idea as in the patient. Platelets aggregate, the coagulation cascade activates, thrombin converts fibrinogen to fibrin, and a fibrin mesh locks cells into a clot. In a red-top or gold/tiger serum-separator tube there is no anticoagulant (gold/tiger tubes add a clot activator). Blood sits until the clot is complete—commonly about 30 minutes at room temperature, following the manufacturer's instructions for use (IFU). Centrifuging too early leaves fibrin strands in the serum (a latent clot) that clog pipettors and invalidate results. Centrifuging after a full clot, then keeping serum on the cells without a barrier, lets cells continue to metabolize glucose and leak potassium; Chapter 7 covers plasma-on-cells time limits. The CMLA point here is mechanical: no anticoagulant + time = clot = serum.
Clotted versus anticoagulated blood
Clotted blood has formed a fibrin clot. The liquid is serum. You cannot resuspend that specimen into whole blood by shaking it. Clotted EDTA or clotted citrate tubes are rejected for hematology and coagulation; they are not a creative source of serum unless the laboratory's procedure explicitly allows a conversion that CMLA should not invent.
Anticoagulated blood has an additive that blocks clotting so cells remain free. After centrifugation, the liquid is plasma. If mixing is skipped, microscopic clots still form: platelet clumps flag a CBC, and a citrate tube with residual clots invalidates PT and aPTT. Anticoagulated is a process (right additive plus immediate mixing), not a stopper color you glance at on the way to the centrifuge.
Why gel separators exist
A serum separator tube (SST) (gold or tiger-top) contains clot activator and a thixotropic gel. After clotting and centrifugation, the gel lodges between the clot and the serum. A plasma separator tube (PST) (light-green lithium heparin) does the same between cells and plasma. The barrier stops cells from eating glucose and leaking potassium and lactate dehydrogenase into the liquid during delays. Gel is not an anticoagulant. An SST still must clot; a PST still must be mixed. Do not assume every green or gold tube is interchangeable with a non-gel tube of similar color—the IFU and the test menu decide.
Why inversion mixing matters
Anticoagulant is concentrated in the tube before blood enters. If the tube stands unmixed, the first milliliter meets a bolus of additive and the last milliliter may never see it. Invert—gentle complete turns, wrist to wrist—the number of times the manufacturer and CLSI specify, immediately after the tube fills. Typical teaching numbers are about 3–4 inversions for citrate and 8–10 for EDTA, heparin, and fluoride; clot-activator serum tubes are inverted about 5 times to mix the activator, then left upright to clot. Those counts are a memory aid; the IFU wins if it differs.
Shaking is not mixing. Shaking shears red cells and causes hemolysis, which falsely raises potassium, lactate dehydrogenase, and aspartate aminotransferase and can invalidate many assays. Hemolysis mechanics are Chapter 7; the foundation is that inversion distributes additive without destroying cells.
EDTA, citrate, heparin, and oxalate/fluoride
Define each additive by mechanism and job. Tube-color order of draw is Chapter 7; you still must know what is in the tube because II.3.B.3 tests improper anticoagulant use.
| Additive | Mechanism | Typical tube job | What goes wrong if you use it for the wrong test |
|---|---|---|---|
| EDTA (ethylenediaminetetraacetic acid; K2 or K3) | Chelates (binds) calcium so the cascade cannot run | Hematology: CBC, differential, hemoglobin A1C in many methods, blood bank EDTA samples | Falsely low calcium and magnesium; K-EDTA falsely high potassium; unacceptable for coagulation |
| Sodium citrate | Binds calcium; calibrated 9:1 blood-to-anticoagulant fill | Coagulation: PT, aPTT, INR | Underfill over-anticoagulates and prolongs times; citrate is not the CBC anticoagulant of choice and dilutes cell counts |
| Heparin (lithium or sodium salt) | Potentiates antithrombin; inhibits thrombin | Plasma chemistry (PST); some special assays | Contaminates coagulation tests (falsely prolonged PT/aPTT); sodium heparin can affect sodium results |
| Potassium oxalate plus sodium fluoride | Oxalate binds calcium (anticoagulant); fluoride inhibits glycolysis (preservative) | Glucose, lactate, some alcohol collections per IFU | Oxalate damages cells and can interfere with enzymes and electrolytes; fluoride is a preservative, not a hematology anticoagulant |
EDTA is the hematology workhorse because cell morphology holds and platelets are stable when mixed. It is the wrong tube for ionized calcium or a chemistry panel that reports potassium and calcium.
Citrate exists for coagulation: the laboratory adds back a measured amount of calcium to start the assay. That is why the fill line is not decorative. A short citrate draw is a different error from a wrong additive, but both ruin the result.
Heparin keeps plasma chemistry moving without waiting for a clot. It is not a substitute citrate tube for a heparinized patient who needs aPTT monitoring—the additive heparin in the tube is not the same problem as therapeutic heparin, but either way you cannot run a valid aPTT on a heparin-plasma chemistry tube.
Fluoride is the preservative half of the gray-top pair: it blocks enzymes in the glycolytic path so glucose stops falling after the draw. Oxalate is the anticoagulant half. Calling fluoride an anticoagulant is the terminology miss; calling oxalate a glucose preservative is the matching miss.
Wrong anticoagulant: preview of the harm
II.3.B.3 will return in Chapter 7 with fill volume and order of draw. The conceptual harm starts here:
- EDTA chemistry tube: chelated calcium reads low; potassium from K-EDTA reads high; iron and alkaline phosphatase can be distorted.
- Heparin coagulation tube: thrombin is inhibited in the tube, so PT and aPTT do not reflect the patient.
- Citrate CBC: extra liquid dilutes hemoglobin, hematocrit, and cell counts; morphology is not EDTA-quality.
- Serum tube submitted for CBC or PT: it clots; platelets are consumed; the analyzer flags clumps or the test cannot be performed.
- Fluoride/oxalate submitted for potassium or enzyme panels: cell damage and enzyme inhibition.
- Unmixed EDTA: residual microclots, falsely low platelet count (pseudothrombocytopenia) or instrument flags.
The assistant action is the same for every row: do not pour blood from one additive tube into another to salvage a missed tube, and do not relabel a wrong-color tube as the test the nurse wanted. Recollect in the correct container.
In practice
A provider orders a CBC, basic metabolic panel, and PT. You understand the metabolic panel may be serum or lithium-heparin plasma per the laboratory directory, the CBC must be EDTA whole blood, and the PT must be a full citrate plasma tube. You mix each additive tube by inversion as it comes off the needle. You do not shake, you do not pour EDTA into the citrate tube when the blue top underfills, and you do not centrifuge the EDTA tube to make serum for chemistry.
Exam traps
- Serum and plasma are not synonyms because both are yellow liquids.
- Whole blood is not plasma with the cells left in out of laziness; it is a different validated specimen.
- Gel does not replace anticoagulant or clot time.
- Fluoride preserves glucose; EDTA chelates calcium; heparin inhibits thrombin; citrate is the 9:1 coagulation additive.
- Shaking is not thorough mixing.
When a stem names a specimen type, answer with fibrinogen, cells, and the additive mechanism—not with a color you memorized without the job.
Which statement correctly distinguishes serum from plasma?
Why is EDTA the routine anticoagulant for a complete blood count, and what is its mechanism?
A laboratory assistant shakes an EDTA tube hard to mix it, leaves a heparin tube unmixed, and pours leftover EDTA blood into a chemistry tube that was missed on the draw. Which statement best describes the preanalytical harm?